Some biohackers and longevity seekers are using the diabetes drug Metformin off-label as a “hack” for better health and longevity, but the research indicates that might not be such a good idea. Studies suggest that metformin may blunt key physiological benefits derived from exercise, raising caution for its use in healthy, physically active individuals.
Metformin, a common Type 2 diabetes drug, is also researched for anti-aging effects. However, recent studies indicate that combining it with exercise interferes with exercise-induced adaptations. This is important because exercise is the number one anti-aging hack for many reasons. It’s literally the closest thing we have to the fountain of youth, so anything that interferes with it sabotages this powerful hack.
-
Aerobic Fitness: Metformin blocked the average 6% improvement in max seen in placebo groups after 16 weeks of low- or high-intensity exercise.
-
Metabolic Health: It attenuated improvements in fasting blood glucose and prevented gains in whole-body insulin sensitivity, even after high-intensity exercise.
-
Vascular Function: It diminished improvements in macrovascular (e.g., large artery widening) and microvascular blood flow insulin sensitivity that normally occur with exercise.
-
Muscle Adaptations: Other trials show metformin also interferes with resistance training gains in lean body mass, muscle mass, and strength.
Proposed Mechanisms for Interference
The study suggests three main biological mechanisms for how metformin dampens exercise effects:
-
Vasoconstrictor/Vasodilator Imbalance: Metformin increased nitric oxide (NO) precursors (vasodilator) but also elevated endothelin-1 (), a potent vasoconstrictor, likely counteracting NO’s beneficial effects on vessel widening (vasodilation).
-
Anti-inflammatory Blunting: Exercise + placebo reduced the inflammatory marker , but exercise + metformin blunted this anti-inflammatory adaptation.
-
Mitochondrial Inhibition: Metformin inhibits mitochondrial complex I, which lowers oxidative stress. However, this oxidative stress signal is necessary during exercise to activate AMPK, a crucial enzyme for vascular and other beneficial training adaptations.
Conclusion on Longevity Use
-
Diabetes Treatment: Metformin remains an excellent, safe first-line therapy for Type 2 diabetes and high cardiometabolic risk, particularly for those who struggle to exercise.
-
Longevity Drug Caution: For healthy, physically active people, caution is warranted. Any supposed longevity upside is based on indirect data, while trial evidence shows it blunts the most powerful longevity intervention: exercise adaptations (especially max, a strong predictor of mortality).
-
Timing Issue: Metformin’s effects are chronic and its acute effects last about 36 hours, suggesting that simply altering the timing away from a workout may not prevent the interference. The best “longevity drug” is intense Xercise!
Research Citations:
-
1. Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome
-
Malin, S. K., Heiston, E. M., Battillo, D. J., et al. The Journal of Clinical Endocrinology & Metabolism. 2025.
-
Link to PubMed: Metformin Blunts Vascular Insulin Sensitivity After Exercise Training
-
-
2. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al. The New England Journal of Medicine. 2002; 346(6): 393–403.
-
-
3. Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-Analysis taking into account Biases and Confounders
-
Zhang, P., et al. PLoS One. 2014; 9(6): e98377.
-
-
4. Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis
-
Xu, W., et al. Frontiers in Neuroscience. 2022; 16: 984559.
-
Link to Frontiers: Metformin use and reduced risk of cognitive impairment
-
Latest Posts
